There have been increasing calls to waive patent protections on pharmaceuticals amid the Covid-19 pandemic, including Prime Minister Muhyiddin Yassin promoting the production of cheaper generic versions of medication for critical diseases. We look at the challenges that come with waiving medication patent and how this move might impact health equity.

Image Source: Volodymyr Hryshchenko, Unsplash

Produced by: Tasha Fusil, Kelvin Yee

Presented by: Lee Chwi Lynn, Sharmilla Ganesan

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  Evening Edition,  Policy and Governence,  Social Issues,  Pharmaceuticals,  Medication,  Vaccinations,  Vaccine,  Covid-19,  Pandemic,  License,  Patent,  Government/Regulatory/Policy Making,  Healthcare, Pharma, Biotech,  Politics, News, Current Affairs,  Health